Command Palette

Search for a command to run...

welcure-drugs-&-pharmaceuticals

8.05+4.95%
Market Cap
₹86.18 Cr
Stock P/E
-48.54
ROCE
-34.66%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Laggard

Welcure Drugs & Pharmaceuticals Ltd. stands out as a significant underperformer in its sector, characterized by negative growth metrics, no profitability, and an excessively high PEG ratio. In contrast, peers like Redington Ltd. demonstrate strong profitability and growth, making them more attractive overall.

Key Points
  • Welcure has negative revenue growth and EPS, indicating financial distress.
  • Redington Ltd. shows strong profitability with the highest ROE and low valuation metrics.
  • Companies like Adani Enterprises and Cello World exhibit substantial growth and efficiency.
Top Performers
Redington Ltd.

Strong revenue growth and high ROE with attractive valuation metrics.

Adani Enterprises Ltd.

Solid revenue growth and good profitability metrics despite higher valuation.

Cello World Ltd.

High growth and efficiency with strong ROE and EBITDA margins.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.